Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2892960 | 0.83 | USP2 (0.47) | USP2SMN1; SMN2GPR119HPGDEPHX2 | |
| SCHEMBL18587326 | 0.82 | USP2 (0.46) | USP2SMN1; SMN2GPR119HPGDEPHX2 | |
| SCHEMBL25034617 | 0.81 | USP2 (0.45) | USP2SMN1; SMN2GPR119HPGDEPHX2 | |
| SCHEMBL4690324 | 0.79 | USP2 (0.44) | USP2SMN1; SMN2HPGDEPHX2RECQL | |
| SCHEMBL2110103 | 0.79 | USP2 (0.47) | USP2SMN1; SMN2GPR119HPGDEPHX2 | |
| SCHEMBL2110226 | 0.78 | USP2 (0.49) | USP2SMN1; SMN2GPR119HPGDEPHX2 | |
| SCHEMBL1973674 | 0.78 | USP2 (0.49) | USP2SMN1; SMN2GPR119HPGDEPHX2 | |
| SCHEMBL16049642 | 0.78 | USP2 (0.43) | USP2SMN1; SMN2GPR119HPGDEPHX2 | |
| SCHEMBL31282949 | 0.78 | TSHR (0.44) | USP2SMN1; SMN2HPGDEPHX2ATM | |
| SCHEMBL741512 | 0.78 | USP2 (0.43) | USP2SMN1; SMN2GPR119HPGDEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180086709-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | DONG-A ST CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086709-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | GALE, UGDH, PGLS | USP2 1078/4885SMN1; SMN2 4701/4885GPR119 372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.